BioCryst Pharmaceuticals Inc (BCRX)

NASDAQ HEALTHCARE
$8.99 +0.45% RSI 55 Neutral Add Alert

Moving Averages

SMA 200
$7.92
Price above

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$2.20B
P/E Ratio
None
EPS
$-1.77
Beta
0.565
Dividend Yield
0.00%
52-Week High
$10.46
52-Week Low
$6

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 64.0
CGC
Canopy Growth Corporation
RSI 37.0
BFRI
Biofrontera Inc
RSI 55.0
TLRY
Tilray Brands Inc - Class 2
RSI 33.0
LNTH
Lantheus Holdings Inc
RSI 63.0
ACB
Aurora Cannabis Inc
RSI 32.0
INM
InMed Pharmaceuticals Inc
RSI 59.0
ORGO
Organogenesis Holdings Inc - Class A
RSI 50.0
ZTS
Zoetis Inc - Class A
RSI 57.0
AQST
Aquestive Therapeutics Inc
RSI 52.0

Data last updated: June 13, 2026 at 12:42 AM EDT

Track BCRX for free

Get e-mail RSI alerts when BioCryst Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert